Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients

Diabetologia
|October 1, 2013
PubMed
Abstract

Insights

Metalloproteinase-10 (MMP-10) is linked to diabetic nephropathy and retinopathy in type 1 diabetes. Lowering MMP-10 may slow the progression of these microvascular complications.

Area of Science:

  • Endocrinology
  • Immunology
  • Ophthalmology

Background:

  • The role of metalloproteinase-10 (MMP-10) in type 1 diabetes remains unclear.
  • MMP-10 is a proteinase implicated in tissue remodeling and inflammation.

Purpose of the Study:

  • To investigate the association between serum MMP-10 levels and microvascular complications in type 1 diabetes.
  • To determine the role of MMP-10 in diabetic nephropathy and retinopathy using a mouse model.

Main Methods:

  • Serum MMP-10 levels were measured in 269 type 1 diabetes patients.
  • The impact of MMP-10 gene knockout on renal and retinal damage was assessed in a streptozotocin-induced diabetic mouse model.

Main Results:

  • Higher MMP-10 levels correlated with increased risk of nephropathy and proliferative retinopathy, independent of traditional risk factors.
  • Diabetic mice lacking Mmp10 showed better renal preservation and reduced retinal neuronal loss and inflammation compared to wild-type counterparts.
  • MMP-10 appears to promote inflammation, evidenced by increased kidney macrophages in wild-type diabetic mice.

Conclusions:

  • MMP-10 plays a significant role in the development of microvascular complications in type 1 diabetes.
  • MMP-10 is a potential therapeutic target for mitigating diabetic nephropathy and retinopathy progression.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...